Impressive survival data with semimetronomic oral chemotherapy with old agents in heavily treated metastatic breast cancer patients

被引：0
|
作者：
Mutlu, H. [1 ,2 ]
Bozcuk, H. [1 ,2 ]
Ozdogan, M. [1 ,2 ]
Artac, M. [1 ,2 ]
Coskun, H. S. [1 ,2 ]
Kargi, A. [1 ,2 ]
Uysal, M. [1 ,2 ]
Savas, B. [1 ,2 ]
机构：
[1] Akdeniz Univ, Sch Med, TR-07058 Antalya, Turkey
[2] Selcuk Univ, Meram Sch Med, Konya, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1082
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Metronomic oral chemotherapy with old agents in patients with heavily treated metastatic breast cancer
    Mutlu, Hasan
    Musri, Fatma Yalcin
    Artac, Mehmet
    Kargi, Aysegul
    Ozdogan, Mustafa
    Bozcuk, Hakan
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (02) : 287 - 290
  • [2] Increased survival for heavily pre-treated metastatic breast cancer
    Siddall, Rhonda
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2010, 71 (07) : 370 - 370
  • [3] ADHERENCE TO AND PERSISTENCE WITH AN ORAL METRONOMIC CHEMOTHERAPY WITH CAPECITABINE IN HEAVILY PRETREATED METASTATIC BREAST CANCER (MBC) PATIENTS
    Fedele, P.
    Nacci, A.
    Orlando, L.
    Marino, A.
    Cinefra, M.
    Cinieri, S.
    ANNALS OF ONCOLOGY, 2010, 21 : 120 - 121
  • [4] ADHERENCE TO AND PERSISTENCE WITH AN ORAL METRONOMIC CHEMOTHERAPY WITH CAPECITABINE IN HEAVILY PRETREATED METASTATIC BREAST CANCER (MBC) PATIENTS
    Mazzoni, E.
    Fedele, P.
    Orlando, L.
    Marino, A.
    D'Amico, M.
    Sponziello, F.
    Nacci, A.
    Calvani, N.
    Schiavone, P.
    Rizzo, P.
    Chetri, M. C.
    Cinieri, S.
    CANCER TREATMENT REVIEWS, 2010, 36 : S101 - S101
  • [5] SURVIVAL OF PATIENTS WITH METASTATIC BREAST-CANCER TREATED WITH EITHER COMBINATION OR SEQUENTIAL CHEMOTHERAPY
    CHLEBOWSKI, RT
    IRWIN, LE
    PUGH, RP
    SADOFF, L
    HESTORFF, R
    WIENER, JM
    BATEMAN, JR
    CANCER RESEARCH, 1979, 39 (11) : 4503 - 4506
  • [6] SURVIVAL OF PATIENTS WITH METASTATIC BREAST-CANCER TREATED WITH EITHER COMBINATION OR SEQUENTIAL CHEMOTHERAPY
    CHLEBOWSKI, R
    IRWIN, L
    PUGH, R
    SADOFF, L
    HESTORFF, R
    WEINER, J
    BATEMAN, JR
    CLINICAL RESEARCH, 1979, 27 (01): : A53 - A53
  • [7] Daily oral etoposide in patients with heavily pretreated metastatic breast cancer
    Pusztai, L
    Walters, RS
    Valero, V
    Theriault, RL
    Hortobagyi, GN
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (05): : 442 - 446
  • [8] Survival without quality of life decrease in old women with metastatic breast cancer treated by chemotherapy.
    Carola, E
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 103S - 103S
  • [9] Oral etoposide in heavily pre-treated metastatic breast cancer: A retrospective series
    Giannone, G.
    Milani, A.
    Ghisoni, E.
    Genta, S.
    Mittica, G.
    Montemurro, F.
    Valabrega, G.
    BREAST, 2018, 38 : 160 - 164
  • [10] The role of chemotherapy and targeted agents in patients with metastatic breast cancer
    Johnston, Stephen R. D.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S38 - S47
12345